But adults under 65 with at least $51,000 in annual income – and private health insurance coverage – saw their costs increase by $3,100 per year during the same period. And that increase magnified the financial havoc cancer can cause.
We wanted to learn how the ACA had changed what cancer patients spend on treatment costs. To find out, we examined data from a U.S. government database spanning the years 2011 to 2020. We excluded people treated for nonmelanoma skin cancer, because it’s more easily treatable than other cancers.
These expenditures included health insurance premiums and out-of-pocket costs such as copays, deductibles, hospital stays, doctor’s office visits, emergency services and home health care services. We compared these costs over the three years before the ACA’s implementation, 2011 to 2013, and the seven years after, 2014 to 2020.
We excluded people 65 or older to focus on patients in the workforce. We also adjusted all costs for inflation, expressing them in 2020 dollars, and took steps to not let insurance status changes affect our results.
Treatment costs for the more than 16 million Americans who were 18 to 64 and had cancer from 2011 to 2020 varied based on their income.
For those eligible for Medicaid, spending fell by about 31% from an average of $4,000 annually in 2014 to $2,750 in 2020.
Cancer patients with at least $51,040 in annual income spent an average of $13,000 annually on health care costs before the ACA’s implementation. Their costs increased by up 24%, an average of $3,120, by 2020.
These people were also more than twice as likely after the ACA’s rollout as before it to spend a large part of their income on health care – making it hard for them to afford other basics such as food and housing.
Cancer treatment costs for people with annual incomes ranging from about $17,600 to $51,000 declined somewhat but not significantly.
What patients pay varies, based largely on whether they have insurance coverage and what kind it is. Costs for cancer patients also vary based on their treatments and how well they tolerate them . The costs of drugs, doctors appointments and hospital services range widely .
New cancer treatments are promising, but many of them are very expensive. In 2022, the average yearly cost of cancer treatments reached $260,000 per patient, compared with $63,500 10 years earlier .
However, not all cancer patients are benefiting from these medical advances. So my research team is now working on creating predictive models to help health care providers match patients to the treatments that they’re most likely to respond well to.
The Research Brief is a short take about interesting academic work.
This article is republished from The Conversation , a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Olajumoke Olateju , University of Houston
Olajumoke Olateju does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Get updates delivered to you daily. Free and customizable.
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. We strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation. Join us in shaping the news narrative together.
Comments / 0